文献速递胃肠外科围术期管理与 ERAS

经口无切口胃底折叠术系统的不良事件与器械故障:MAUDE数据库分析

Adverse events and device failures of the transoral incisionless fundoplication system: a MAUDE database analysis.
PubMed 文献 · Surg Endosc · 2026-08-13

该研究基于FDA MAUDE数据库分析EsophyX经口无切口胃底折叠术(TIF)相关不良事件与器械故障,去重后共纳入192份MDR报告。结果显示报告量自2020年起急剧上升,以严重患者伤害为主,最常见为穿孔、食管/黏膜损伤、肺部/胸膜并发症、疼痛、感染/脓毒症和出血,器械故障以置入/推进/取出困难最常见。

要点

  • TIF/cTIF相关MAUDE报告自2020年起显著增加,2023-2025年分别为26、40、33份。
  • 患者不良事件占71.9%,最常见为穿孔(58.0%),Cotton分级严重事件占49.3%。
  • 器械故障占45.8%,以置入/推进/取出困难(30.7%)和组件脱落/断裂(23.9%)为主。

核心结论

  • MAUDE报告中TIF/cTIF相关不良事件以严重患者伤害为主,尤其穿孔、肺部并发症、出血和机械故障,需推动操作标准化、资质认证路径和前瞻性安全登记。

研究设计与样本

  • 基于FDA MAUDE数据库的回顾性分析,提取截至2026年3月EsophyX器械家族和SerosaFuse fastener kit的MDR报告,去重后分析192份唯一报告。
  • 报告按患者不良事件和器械故障分类,严重程度采用改良Cotton分级。

主要发现

  • 192份报告中130份为损伤、60份为故障、2份为死亡;年报告量从2016-2019年的8.8份/年升至2023-2025年的26、40、33份。
  • 患者不良事件见于138份报告(71.9%),器械故障见于88份(45.8%)。
  • 最常见事件为穿孔(58.0%)、食管/黏膜损伤(27.5%)、肺部/胸膜并发症(21.0%)、疼痛(21.0%)、感染/脓毒症(20.3%)和出血(19.6%)。
  • 发现5例操作相关死亡(占患者事件报告的3.6%),其中仅2例被FDA归为死亡分类;Cotton分级严重事件占49.3%,致命占3.6%。
  • 34.4%需外科干预,29.2%需住院,16.7%需内镜补救;穿孔在cTIF中报告率为56.6%,单纯TIF为30.3%。

关键数值与推荐

  • 器械故障以置入/推进/取出困难(30.7%)、组件脱落(23.9%)、断裂(23.9%)和机械卡滞(22.7%)为主。

临床怎么用

  • 临床开展TIF/cTIF时应警惕穿孔、肺部并发症和出血等严重不良事件,并关注器械置入困难和组件脱落等故障信号。
  • 建议推动操作标准化、术者资质认证和前瞻性安全登记,以补充上市后安全数据。

局限性

  • MAUDE数据库存在自发报告偏倚、报告不完整和漏报等固有局限性,无法计算真实发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transoral incisionless fundoplication (TIF) using the EsophyX device, with or without concomitant laparoscopic hiatal hernia repair (cTIF), is increasingly used for GERD. Postmarketing safety data are limited. We analyzed the FDA MAUDE database to characterize adverse events and device failures. METHODS: We extracted MDRs for the EsophyX device family and SerosaFuse fastener kit submitted through March 2026. Duplicates were removed by MDR identifier and narrative matching. Reports were classified for patient adverse events and device failures; severity was graded using a modified Cotton lexicon. RESULTS: After deduplication, 192 unique MDRs were analyzed (130 Injury, 60 Malfunction, 2 Death). Annual reports rose from 8.8/year in 2016-2019 to 26, 40, and 33 in 2023-2025. Adverse events occurred in 138 reports (71.9%) and device failures in 88 (45.8%). Most frequent events were perforation (58.0%), esophageal/mucosal injury (27.5%), pulmonary/pleural complications (21.0%), pain (21.0%), infection/sepsis (20.3%), and bleeding (19.6%). Five procedure-related deaths (3.6% of patient-event reports) were identified, of which only two were filed by FDA under the Death classification. By Cotton severity, 49.3% were severe and 3.6% fatal. Surgical intervention occurred in 34.4%, hospitalization in 29.2%, endoscopic rescue in 16.7%. Perforation was reported in cTIF in 56.6% and 30.3% TIF alone. Dominant failures were insertion/advancement/removal difficulty (30.7%), component detachment (23.9%), breakage (23.9%), and mechanical jam (22.7%). CONCLUSIONS: MAUDE reports have risen sharply since 2020, dominated by severe patient harm, particularly perforation, pulmonary complications, bleeding, and mechanical failures. Despite MAUDE's limitations, the predominance of severe events warrants procedural standardization, credentialing pathways, and prospective safety registries as TIF/cTIF use expands.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Amdetsion GY, Ayele T, Oleas R, et al. Adverse events and device failures of the transoral incisionless fundoplication system: a MAUDE database analysis. Surg Endosc. 2026. PMID: 42595909. doi:10.1007/s00464-026-13264-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。